ARCA biopharma extends headquarters lease through September 2024 at increased rent

Oruka Therapeutics, Inc.

Lease extended 6 months to Sept 30, 2024; base rent raised to $8,206.42/month from April 1.
After extension, month-to-month tenancy at 125% of Sept 2024 base rent if tenant remains.
Company must provide 60-day vacate notice; landlord may market space during extension period.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Oruka Therapeutics, Inc. amended First Amendment to Office Lease Agreement with Lotus Church Ranch, LLC valued at $8,206.42 (effective 2024-03-19).

Action: amendment
Agreement: lease
Counterparty: Lotus Church Ranch, LLC
Value: $8,206.42
Effective: 2024-03-19

Exact text from the filing

On March 19, 2024, ARCA biopharma, Inc., a Delaware corporation (“ARCA”), entered into the First Amendment to Office Lease Agreement (the “Lease Amendment”) with Lotus Church Ranch, LLC (the “Landlord”), which amended that certain Office Lease Agreement, dated as of August 7, 2020, related to the Company’s headquarters in Westminster, Colorado (the “Lease”). Under the Lease Amendment, the term of the Lease was extended an additional six (6) months through September 30, 2024 (the “Lease Extension”). Commencing on April 1, 2024, the minimum monthly rent shall be increased to $8,206.42.

View on SEC.gov

380 material agreements filed in the last 30 days. Browse all material agreements →

Oruka Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-035373

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.